Last updated on June 2018

A Study to Investigate Efficacy Safety Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis


Brief description of study

The purpose of this study is to investigate efficacy, safety and tolerability of ASP6294 in female participants with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC). This study will also investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of ASP6294 in female participants with BPS/IC.

Clinical Study Identifier: NCT03282318

Contact Investigators or Research Sites near you

Start Over

Clinical Science

Site CZ42003
Praha 4, Czechia
  Connect »

Clinical Science

Site LV37103
Daugavpils, Latvia
  Connect »

Clinical Science

Site LV37101
Riga, Latvia
  Connect »

Clinical Science

Site LV37102
Riga, Latvia
  Connect »

Clinical Science

Site LV37105
Riga, Latvia
  Connect »

Clinical Science

Site BE32002
Edegem, Czechia
  Connect »

Clinical Science

Site CZ42001
Kromeriz, Czechia
  Connect »

Clinical Science

Site CZ42002
Plzen, Czechia
  Connect »

Clinical Science

Site DE49011
Berlin, Germany
  Connect »

Clinical Science

Site DE49003
Duisburg, Germany
  Connect »

Clinical Science

Site DE49007
Duisburg, Germany
  Connect »

Clinical Science

Site DE49001
Holzminden, Germany
  Connect »

Clinical Science

Site DE49005
Markkleeberg, Germany
  Connect »

Clinical Science

Site DE49010
Monchengladbach, Germany
  Connect »

Clinical Science

Site DE49002
Nuertingen, Germany
  Connect »

Clinical Science

Site HU36002
Budapest, Hungary
  Connect »

Clinical Science

Site HU36001
Csongrad, Hungary
  Connect »

Clinical Science

Site HU36006
Gyor, Hungary
  Connect »

Clinical Science

Site NL31002
Doetinchem, Netherlands
  Connect »

Clinical Science

Site NL31005
Nijmegen, Netherlands
  Connect »

Clinical Science

Site NL31001
Rotterdam, Netherlands
  Connect »

Clinical Science

Site NL31007
Sneek, Netherlands
  Connect »

Clinical Science

Site PL48003
Bialystok, Poland
  Connect »

Clinical Science

Site PL48004
Chorzow, Poland
  Connect »

Clinical Science

Site PL48006
Katowice, Poland
  Connect »

Clinical Science

Site PL48009
Lodz, Poland
  Connect »

Clinical Science

Site PL48001
Lublin, Poland
  Connect »

Clinical Science

Site PL48002
Szczecin, Poland
  Connect »

Clinical Science

Site PL48010
Warszawa, Poland
  Connect »

Clinical Science

Site PL48007
Wroclaw, Poland
  Connect »

Clinical Science

Site ES34006
Barcelona, Spain
  Connect »

Clinical Science

Site ES34005
La Cuesta, Spain
  Connect »

Clinical Science

Site ES34003
Madrid, Spain
  Connect »

Clinical Science

Site ES34008
Madrid, Spain
  Connect »

Clinical Science

Site ES34002
Malaga, Spain
  Connect »

Clinical Science

Site ES34007
Valencia, Spain
  Connect »

Clinical Science

Site GB44001
Glasgow, United Kingdom
  Connect »

Clinical Science

Site GB44002
Manchester, United Kingdom
  Connect »

Clinical Science

Site GB44006
Plymouth, United Kingdom
  Connect »

Clinical Science

Site GB44004
Wrexham, United Kingdom
  Connect »

Clinical Science

Site BE32001
Leuven, Belgium
  Connect »

Clinical Science

Site ES34001
Barcelona, Spain
  Connect »

Clinical Science

Site RU70001
St. Petersburg, Russian Federation
  Connect »

Clinical Science

Site RU70006
St. Petersburg, Russian Federation
  Connect »

Clinical Science

Site RU70008
St. Petersburg, Russian Federation
  Connect »

Clinical Science

Site RU70005
Moscow, Russian Federation
  Connect »

Clinical Science

Site RU70002
St. Petersburg, Russian Federation
  Connect »

Clinical Science

Site RU70003
St. Petersburg, Russian Federation
  Connect »